ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement contractpharma
February 23, 2021MaxiVAX SA and Minaris Regenerative Medicine GmbH have entered into a manufacturing agreement for MVX-ONCO-2, a cell-based immunotherapy for the treatment of cancers such as chordoma, head and neck, and other solid tumors.
Pharma Sources Insight January 2025
